What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Savara SVRA Price / sales

Discontinued — last reported Q4 '20

Price / sales at other companies

XER

Xeris Biopharma Holdings, Inc.XERS

3.2×-0.6×

Zevra Therapeutics, Inc.ZVRA

4.5×-5.5×

Innoviva, Inc.INVA

4.1×+1.0×

Theravance BiopharmaTBPH

7.6×+0.8×

ANI PharmaceuticalsANIP

1.9×-0.3×

Eton Pharmaceuticals, Inc.ETON

7.7×+0.5×

Other financials

Income statement

See full

Revenue-—

Operating income-$39.0M-37.1%

Net income-$37.3M-40.0%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$38.8M+98.4%

Total debt$30.1M+1.8%

Total equity$176.0M+19.1%

Total assets$221.6M+17.1%

Cash flow

See full

Operating cash flow-$33.0M-21.5%

CapEx$54.0K+1,700%

Free cash flow-$33.1M-21.7%

Valuation

See full

Market cap$1.19B+236%

Enterprise value$1.19B+224%

Profitability

See full

Operating margin-19,183.3%—

Net margin-19,305.1%—

FCF margin-15,518.7%—

Returns & leverage

See full

Return on equity-80%+4.7pp

Debt / equity0.2×0.0×

Current ratio13.5×-1.4×

Where this comes from

Calculated from Savara’s reported figures.

market cap/total revenue=344.5×

Based on the most recent quarter.

The official record: Savara’s 10-K, filed March 30, 2022, on SEC EDGAR. View the filing →

Questions, answered.

What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.